Exagen Inc
(XGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 11,230 | 12,837 | 14,726 | 7,606 | 10,394 |
| Cost of Goods | 5,926 | 6,309 | 6,010 | 6,078 | 5,817 |
| Gross Profit | 5,304 | 6,528 | 8,716 | 1,528 | 4,577 |
| Operating Expenses | 13,936 | 21,328 | 16,543 | 15,670 | 15,073 |
| Operating Income | -7,706 | -14,491 | -7,817 | -14,064 | -9,679 |
| Interest Expense | 638 | 626 | 618 | 606 | 598 |
| Other Income | 656 | 481 | 339 | 5 | 5 |
| Pre-tax Income | -7,688 | -14,636 | -8,096 | -14,665 | -10,272 |
| Net Income Continuous | -7,688 | -14,354 | -8,096 | -14,665 | -10,272 |
| Net Income | $-7,688 | $-14,354 | $-8,096 | $-14,665 | $-10,272 |
| EPS Basic Total Ops | -0.44 | -0.84 | -0.47 | -0.86 | -0.60 |
| EPS Basic Continuous Ops | -0.44 | -0.84 | -0.47 | -0.86 | -0.60 |
| EPS Diluted Total Ops | -0.44 | -0.84 | -0.47 | -0.86 | -0.60 |
| EPS Diluted Continuous Ops | -0.44 | -0.84 | -0.47 | -0.86 | -0.60 |
| EBITDA(a) | $-7,111 | $-8,423 | $-7,336 | $-13,710 | $-9,358 |